David Benshoof Klein is a healthcare investor and entrepreneur with over 15 years of life science industry experience; he has played key roles in founding, financing and developing more than 10 life science companies. In 2012, Mr. Klein co-founded Click Therapeutics, Inc, which focuses on engineering, validating and commercializing Digital Therapeutics™ solutions to benefit people with unmet medical needs through cognitive and neurobehavioral modification. He formerly served as Managing Director at a life science asset management firm, senior consultant to Pfizer, and strategic advisor to numerous publicly-traded and privately-held life science companies. Mr. Klein is an avid art enthusiast and is co-founder and owner of Klein Sun Gallery, America’s leading Chinese contemporary art gallery with locations in New York’s Chelsea art district and Beijing, China. A native New Yorker, Mr. Klein has been a guest lecturer at Columbia University’s Biotechnology Program, and holds a B.A. from Brandeis University.
Who’s Dominating in Digital Therapeutics?